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Abstract
Background: Probiotics are microorganisms, mainly bacteria, which benefit the host’s health. Many studies sup-
port the role of probiotics as a contributor to gastrointestinal health, and nowadays many authors are trying to 
prove its influence in oral health maintenance. 
Objectives: To review the published literature with the purpose of knowing the importance of using probiotics as 
a preventive and therapeutic method for oral infectious diseases management. 
Material and Methods: An electronic search in PubMed database with the keywords “oral health AND probiotics 
AND dentistry” was conducted. The inclusion criteria were: randomized clinical trials (RCTs) that assess the ac-
tion of any probiotic strain in the treatment and / or prevention of an infectious oral disease, RCTs that assess the 
action of any probiotic strain on counting colony forming units (CFU) of oral pathogens, systematic reviews and 
meta-analysis. The Jadad scale was used to assess the high quality of RCTs. 
Results: Fifteen articles were considered for this review. Of which, 12 were RCTs of good / high quality (Jadad 
scale), two meta-analysis and one systematic review. 
Conclusions: The literature reviewed suggests probiotics usage could be beneficial for the maintenance of oral 
health, due to its ability to decrease the colony forming units (CFU) counts of the oral pathogens. However, rand-
omized clinical trials with long-term follow-up periods are needed to confirm their efficacy in reducing the preva-
lence/incidence of oral infectious diseases. Furthermore, the recognition of specific strains with probiotic activity 
for each infectious oral disease is required, in order to determine exact dose, treatment time and ideal vehicles.
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Introduction
Periodontal disease and dental caries are one of the most 
prevalent and important health problems worldwide (1,2). 
The treatment of these diseases or their complications 
may require systemic use of antimicrobial drugs; which 
trigger gastrointestinal side effects due to broad spectrum 
antibiotics (3), bacterial resistance and allergic reactions 
(4-6). For this reason, many authors have proposed alter-
native therapies that can offer satisfactory results without 
causing potential risks to the patient (7). 
Probiotics are defined as nonpathogenic live microor-
ganisms that, when administered in adequate amounts 
in foods or as dietary supplements, confer benefits to the 
host’s health (6,8-10). They were first proposed by Elie 
Metchnikoff, (Nobel Prize in Physiology and Medicine 
- 1908), who developed the theory that the Bulgarian 
population had greater longevity due to the consump-
tion of fermented products containing lactic acid bac-
teria that improved gastrointestinal health (5,6,8). Since 
then, many publications refer to the use of probiotic 
strains (mainly Lactobacilli and Bifidobacteria) in the 
maintenance of gastrointestinal, genitourinary and oral 
health through providing the balance of these ecosys-
tems (5,6,8-11).
The oral cavity is a microbiological medium that needs 
homeostasis (6,10). When factors such as time, poor oral 
hygiene, diet and immunodeficiency alter that balance, 
infectious diseases can develop and might require a 
complex management because of their polymicrobial 
nature (11,12). Microorganisms and toxins necessary 
for the destruction of oral tissues are organized in a thin 
film known as biofilm (6,13). This is deposited on the 
hard tissues of the oral cavity: enamel and cementum, 
and the dental implant surface (14). In microbiological 
terms, we can say that is the result of processes such as 
bacterial adhesion, aggregation and co-aggregation to 
colonize the oral cavity (14-16). The aim of this article 
is to review the published literature with the purpose 
of knowing the importance of using probiotics as a 
preventive and therapeutic method for oral infectious 
diseases management.
Material and Methods
An electronic literature search in PubMed database 
between March and May 2016, with the keywords 
“probiotics AND oral health AND dentistry” was 
conducted. No time filter was used to limit the years 
of publication. The inclusion criteria were: randomized 
clinical trials (RCTs) that assess the action of any 
probiotic strain in the treatment and/or prevention of an 
infectious oral disease, RCTs that assess the action of 
any probiotic strain on counting colony forming units 
(CFU) of oral pathogens. Only those with a Jadad > 3 
(17) were considered. Systematic reviews and Meta-
analyzes were also included.
Results     
An initial search resulted in seventy six items. After 
reading all abstracts, 12 studies were eliminated because 
they were not focused on the topic, 1 for being rejected 
by plagiarism and 1 for being unavailable. Seventeen 
in-vitro studies and 19 non-systematic reviews/updates 
were eliminated because they did not coincide with the 
inclusion criteria. In addition, 11 RCTs were discarded 
for not having a Jadad > 3 (Fig. 1). A total of 15 articles 
were considered for this review. Of which 12 were RCTs 
(Table 1), 1 systematic review and 2 meta-analyses. 
RCTs included in this study (18-29) had a total of 1291 
patients (n=1291). Of which, 380 patients were older 
than 18 years old and 911 were minors. Six studies used 
only Lactobacilli  probiotic strains (19,20,23,27-29), 3 
studies Bifidobacteria (24-26), 1 used Streptococci (18), 
and 2 studies used mixtures of probiotic strains  (21,22). 
Seven RCTs evaluated the influence of bacteriotherapy 
in the colony forming units (CFU) counts of S. Mutans 
and dental caries (20-26), 4 in periodontal disease 
(18,19,28,29) and 1 in the CFU counts of Candidas (27). 
Four RCTs employed dairy products as a vehicle for the 
administration of probiotics (20,21,23,24), 6 used oral 
tablets (18,25-29) and 2 used powder sachets (19,22). 
Of the latter, Jindal G et al. (22) used it diluted as a 
mouthwash. Eight studies had an intervention time equal 
or greater than 8 weeks (18,19,20,23,25-27,29). The 
remaining four studies lasted 7 to 18 days (21,22,24,28). 
In 6 studies, patients were followed up only during the 
intervention time (23-25,27-29). Laleman I, et al. (18) 
and Ashwin D et al. (21) did a 6 months follow-up, 
Wattanarat O, et al. (20) and Morales A et al. (19) did 
a 1 year follow-up and Taipale T et al. (26) a 4 years 
follow-up.
Discussion                                       
The mechanism of probiotics in the oral cavity is not 
clearly established. They are associated with decreased 
CFU counts of cariogenic pathogens and the inhibition 
of periodontal pathogens (18,19,30,31). Furthermore, 
they modulate the inflammatory response (humoral and 
cellular) and produce substances such as lactic acid, hy-
drogen peroxide and bacteriocins (antimicrobial agents 
produced by lactic acid bacteria, whose action provides 
them of the probiotic effect) (8,13,30). Most of the stud-
ies reviewed mention its ability to compete with patho-
gens for adhesion surfaces and nutrients, causing the 
displacement of the latter ones (15,16).
None of the studies reviewed reported side effects as-
sociated with this bacteriotherapy (18-29). However, 
Taipale T, et al. (26) explained that in their study 2 pa-
tients from the intervention group with probiotics were 
removed because of gastrointestinal discomfort and 
2 patients from the control groups with placebo were 
removed for the same reason and atopic eczema. None 
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of the authors used probiotics as a therapeutic, preven-
tive or adjuvant method in immunosuppressed patients. 
Probably because of ethical reasons associated to the 
inherent risks of their systemic condition. Rao Y, et 
al. (32) and Saraf K, et al. (33) referred to the use of 
this bacteriotherapy in patients with HIV and cancer to 
boost the immune system and fight allergies; however, 
they recognized that their use in oral health mainte-
nance has not yet been tested. 
The two most important topics reviewed in the studies 
included in this systematic review are periodontal dis-
ease and dental caries, which are described separately.
* i.- Probiotics and Dental caries
Dental caries is a multifactorial disease. Its pathogen-
esis involves the microbiota (mainly, S. Mutans ), the 
host and its immune mechanisms, as well as the diet 
among other factors (1,6,11). Even though all these fac-
tors have to intervene in order for dental caries to de-
velop, microbiological factors are still the leading cause 
of this disease. Therefore, it is thought that this bac-
teriotherapy could influence positively in the preven-
tion of this disease (6,11,31,34). In the meta- analysis 
performed by Laleman I, et al. (11), of the 725 stud-
ies found in the databases PUBMED and ISI Web of 
KnowledgeSM, only 19 met the inclusion criteria and 
were used for the descriptive analysis. Of those, only 2 
assessed the caries prevalence after probiotics therapy. 
Given this limitation, they had to focus on the CFU 
counts of S. Mutans  and Lactobacilli  before and after 
the probiotics treatment. This meta- analysis shows that 
when comparing the intervention group with the con-
trol group before and after the bacteriotherapy, there is a 
significant decrease in CFU counts of S. Mutans , which 
does not happen with the CFU counts of Lactobacilli . 
In addition, after treatment with probiotics, the inter-
vention group had a greater number of patients with low 
levels of S. Mutans  CFU counts (< 105 CFU / ml) and 
fewer patients with high levels (> 106 CFU / ml), which 
does not occur in the control group, neither when the 
same comparison with Lactobacilli  CFU counts was 
performed. Of the 19 studies used for the descriptive 
analysis of this meta-analysis; only two had low risk of 
bias; ten had a moderate risk, and seven high risk [based 
on assessment criteria from the Cochrane Center, Con-
sort Guide (35), Delphi list (36), and the list proposed 
by Van der Weijden, et al. (37)]. The high probability of 
bias and the number of studies used, make us think that 
the results of this study may not be applicable. However, 
the authors explained that this limitation is based on the 
fact that the studies published have very heterogene-
ous methodologies; due to the study design, treatment 
and follow-up time, probiotic strains, concentrations 
Fig. 1.  Selection process of the studies included in this systematic review.
!
!
!
«Probiotics AND oral health AND dentistry» 
PUBMED 
76 studies 
14 discarded 
!
12 not focused on the topic 
01 retracted by plagiarism 
01 unavailable 
62 were analyzed with the inclusion/ 
exclusion criteria 
15 included in this systematic review 
!
17 in-vitro methodology 
19 non-systematic reviews/updates 
11 Clinical trials  (JADAD ‹  3) 
47 discarded 
!
12 RCTs (JADAD ! 3)  
02 meta-analysis 
01 systematic review 
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RCTs JADAD criteria 
Authors/ year N/age Patients Probiotic strain / Vehicle Treatment Follow-up Conclusions Qualification 
Laleman I et al. 
(18) (2015)  48 / 47±5 
Untreated 
periodontal 
patients 
S. Oralis / Tablets 
S. Uber / Tablets 
S. Rattus / Tablets 
12 weeks 24 weeks 
No significant differences 
between groups, respect 
to periodontal health 
improvement. 
[4] High 
Kraft-Bodi E  
et al. (27) (2015)  
174 / 88.3 
±5.7 Unspecified 
L. Reuteri / 
Tablets 12 weeks 
Decrease in Candida CFU 
counts [5] High 
Wattanarat O  
et al. (20) (2015)  60 / 13-15y Unspecified L.Paracasei / Milk 6 months 12 months 
Higher levels of hnp 1-3 
in the intervention group [5] High 
Ashwin D et al. 
(21) (2015)  60 / 6-12y 
No dental 
caries 
B. Lactis (Bb-12) 
/ Ice cream 
L. Acidophilus 
(La-5) / Ice cream 
7 days 6 months 
Decrease in S. Mutans 
CFU counts during the 
probiotics administration 
[3] Good 
Lee JK et al. (28)   
(2015) 
 
34 / 22.1y 
Adults. 
Experiment
al gingivitis 
L. Brevis/ Tablets 14 days 
The usage of probiotics 
retards the development 
of gingivtis 
[5] High 
Taipale T et al. 
(26) (2013)  94 / 4y 
Healthy 
children 
B. Lactis (Bb-12)/ 
Tablets - 4 years 
No significant differences 
in the incidence of dental 
caries 
[3] Good 
Taipale T et al. 
(25) (2012)  
96 / 1-2 
months 
Healthy 
children 
B.Lactis (Bb-12)/ 
Tablets 
24 months 
 
Early administration of 
BB12 does not represent 
its permanent colonization 
in the oral cavity. No 
significant differences 
respect to the S. Mutans 
CFU counts. 
[5] High 
Shimauchi H  
et al. (29) (2008)  
66 / 44.9 ± 
8.3y Unspecified 
L. Salivarius/ 
Tablets 8 weeks 
Probiotics might be a 
good alternative for oral 
health maintenance in 
patients with a high risk 
of periodontal disease. 
[3] Good 
Näse L et al. (23) 
(2001)  
451 / 4.6 ± 
1.3–6.8y Unspecified 
L. Rhamnosus/ 
Milk 7 months 
Consumption of dairy 
products containing 
probiotics could be 
considered as an 
alternative to improve the 
oral health in children. 
[5] High 
Nagarajappa R  
et al.  (24) (2015)  30 / 18-22y 
Dentistry 
students 
Bifidobacteria/ 
Ice cream 18 weeks 
Short-term consumption 
of ice cream containing 
bifidobacteria may reduce 
the s. Mutans cfu counts 
in young adults. 
[5] High 
Morales A et al. 
(19) (2016)  28 / 52.7 ± 7.3y 
Untreated 
periodontal 
patients 
L. Rhamnosus/ 1 
Sachet in 150 ml 
of water 
3 months 12 months 
The use of L.Rhamnosus 
in first step of periodontal 
therapy represents the 
same improvement as 
surgical treatment alone. 
[5] High 
Jindal G et al. 
(22) (2011)  150 / 7-14y 
Children 
without 
infectious 
oral diseases 
L. Rhamnosus 
B. Longum 
Saccharomyces 
cereviasae/ 
Powder: 1g (1.25 
billion of bacteria) 
Bacilus coagulans 
(L. Sporogenes)/ 
Powder: 1g (150 
million of spores) 
14 days 15 days 
Significant decrease in S. 
Mutans CFU counts 
during the intervention 
period. 
[4] High 
!
Table 1. RCTs considered, due to their JADAD qualification.
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and vehicles used, as well as the population selected 
for the study, ages and local contributing factors (ortho-
dontic appliances and dental prostheses).  Laleman I, et 
al. (11); Wattanarat O, et al. (20); Jindal G, et al. (22); 
Nase L, et al. (23); Nagarajappa R, et al. (24) concluded 
that the use of probiotics can reduce S. Mutans  CFU 
counts during the time they are used, and this could 
have a preventive effect on the development of dental 
caries; however, the lack of long-term follow-up periods 
makes it impossible to suggest that the effect continues 
after stopping the bacteriotherapy, or its influence on 
the prevalence/incidence of dental caries. In addition, 
it has to be determined which would be the appropriate 
strain, time of treatment, concentration and the ideal ve-
hicle to be used. On the other hand, Taipale T, et al. (25) 
conducted a 24 months double double-blind study in a 
population of 96 one month old children, which were 
divided into three randomized groups, receiving probi-
otics (B. Lactis BB -12), xylitol or sorbitol. They con-
cluded that early administration of this probiotic strain 
did not represent its permanent colonization in the oral 
cavity and that the CFU counts of S. Mutans  were not 
significantly affected. The same group published a post-
clinical trial of these patients at 4 years-old; confirm-
ing that in that population probiotics therapy did not 
exercise significant differences in the incidence of den-
tal caries, compared to the xylitol and sorbitol control 
groups. Furthermore, in the systematic review made by 
Twetman et al. (8) which reviewed three RCTs that used 
L. Rhamnosus and milk as a vehicle for the prevention/
control of dental caries, they concluded that despite the 
encouraging results about the preventive capacity of 
probiotics in dental caries, it would be premature to give 
any clinical recommendation due to the lack of RCTs 
with a long-term follow-up period. Gruner D, et al. (31) 
conducted a meta-analysis of 50 clinical trials published 
between 2001 and 2015, with a total of 3247 patients 
(n=3247). The authors explained that probiotic therapy 
significantly reduces the S. Mutans  CFU counts (<104 
UFC/ml), and that Bifidobacteria are the most signifi-
cant contributors to this effect. However, if the limit is 
105CFU/ml or 106UFC/ml, there are no significant dif-
ferences with the control group. Unfortunately, accord-
ing to the authors, studies that support those data were 
not clear or had a high risk of bias. For that reason, they 
considered the existing clinical evidence inconsistent to 
make recommendations about the use of probiotics in 
the treatment or prevention of dental caries. Neverthe-
less, as they did not found association between this bac-
teriotherapy and the occurrence of adverse effects, they 
did not recommend its contraindication. The same au-
thors analyzed that RCTs which evaluated Lactobacilli 
(cariogenic bacteria) colonization, showed an increase 
in CFU counts; probably because of the use of probiotic 
strains of the same genus. Therefore, they proposed that 
future RCTs should evaluate cariogenic Lactobacilli 
counts and probiotic Lactobacilli  counts separately. Of 
the 50 clinical trials included in this meta-analysis, 45 
used Lactobacilli  and 12 used Bifidobacteria; which 
coincides with our review.
* ii.- Probiotics and Periodontal Disease 
Imbalance between the saprophytic and pathogenic 
flora of the oral cavity, in a susceptible host, can result 
in periodontal disease (2). Debridement treatment of 
this disease can be surgical or nonsurgical and in some 
cases systemic administration of antimicrobials is re-
quired (19). Due to bacterial resistance associated with 
the prescription of these drugs, new alternatives for 
periodontal health maintenance are needed (6,19). The 
mechanism of probiotics is associated with the produc-
tion of substances (lactic acid, hydrogen peroxide and 
bacteriocins) and the modification of the biofilm (38,39). 
It has also been mentioned a possible decrease of pro- 
inflammatory cytokines, collagenases, elastases and 
prostaglandins E2 levels (40). Piwat S, et al. (15) con-
ducted an in-vitro study that, despite not meeting our 
inclusion criteria, deserves to be commented because 
it is one of the few jobs that explains the adhesion, ag-
gregation and co-aggregation mechanisms of probiotic 
bacteria, and their influence in the probiotic effect. 
In theory, probiotic bacteria attach to the oral tissues 
more strongly than pathogens, being able to compete 
for adhesion surfaces. From this process, bacterial ag-
gregation and co-aggregation are triggered, thus pro-
ducing a new “biofilm” (15,19,30,39). Morales A, et al. 
(19) conducted a clinical study to evaluate the use of 
probiotics as an adjuvant therapy in nonsurgical peri-
odontal treatment in patients with previously untreated 
chronic periodontitis. Although the intervention group 
(14 patients) had lower probing depth than the control 
group, even at one year follow-up, this difference was 
not statistically significant. Therefore, they concluded 
that the adjunctive use of L. Rhamnosussachets provides 
same clinical results as scaling and root planning alone. 
Shimauchi H, et al. (29) found that probiotic treatment 
with L. Salivarius improves plaque index and probing 
depth in smokers. For that reason, they concluded that 
this bacteriotherapy is a good alternative for oral health 
maintenance in patients with high risk of periodontal 
disease. Laleman I, et al. (18) conducted a clinical trial 
in which 48 adults with untreated periodontal disease 
were divided into two groups. The intervention group 
received S. Oralis, S. Uberis y S. Rattus, and the control 
group a placebo. Both groups underwent scaling and 
root planning and had to take 1 tablet (depending on 
the group they belonged) twice a day during 12 weeks 
as an adjunctive therapy. At the end of follow up period 
(24 weeks), they found a significant improvement (p < 
0.05) in periodontal health of both groups. However, 
there were no significant differences between groups at 
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12 weeks of treatment, neither at 24 weeks of follow 
up.  Despite they also found a decreased in Prevotella 
Intemedia CFU counts at 12 weeks of treatment in the 
intervention group compared to the baseline counts (p= 
0.02), they concluded that there were no significant dif-
ferences between groups and that the usage of those 
probiotic strains as an adjuvant therapy after scaling 
and root planning has no clinical nor microbiological 
relevance. In another study, Laleman I, et al. (6) highlight-
ed that the usage of probiotics does not replace the daily 
oral hygiene technique. In the meta-analysis of Gruner D, 
et al. (31), that we have already mentioned, they included 
3 clinical trials which evaluated the influence of probiotic 
therapy with Lactobacilli  in periodontal pathogens counts 
(Agregatibacter Actinomycetemcomitans, Porphyromana 
Gingivalis and Prevotella Intermedia) and no statistically 
significant differences were found compared with the con-
trol group. Nevertheless, when clinical signs such as gingi-
val index and bleeding on probing are assessed, they found 
an improvement in the interventions groups, which did not 
occur with plaque index. This is the reason why they ref-
ered that the probiotic effect may lie in the host response, 
rather than in the periodontal pathogens. However, the risk 
of bias of the considered clinical trials was high. 
Conclusions
Probiotics are a kind of bacteriotherapy which, according 
to the literature reviewed, provides a decrease in CFU 
counts of cariogenic pathogens (S. Mutans ). Regarding 
periodontal disease, the studies included in this review 
reported a clinical improvement of bleeding on probing, 
probing depth and gingival index, but no significant 
difference in CFU counts of periodontal pathogens. 
Anyway, it is important to highlight that these diseases 
have a multifactorial etiology, which means that 
reducing the CFU counts does not ensure their absolute 
control. RCTs with homogeneous methodologies and 
long-term follow-up periods are needed to confirm their 
contribution in the management of these diseases and 
their influence in their prevalence. Furthermore, the 
recognition of specific strains with probiotic activity 
for each infectious oral disease is required in order 
to determine exact dose, treatment time and ideal 
vehicles. 
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